James J. MacDonald - Feb 18, 2022 Form 4 Insider Report for Sana Biotechnology, Inc. (SANA)

Role
EVP & General Counsel
Signature
/s/ James J. MacDonald
Stock symbol
SANA
Transactions as of
Feb 18, 2022
Transactions value $
$16,141
Form type
4
Date filed
2/23/2022, 04:01 PM
Next filing
Mar 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SANA Common Stock Award $18.2K +1K +0.23% $18.23 430K Nov 15, 2021 Direct F1, F2
transaction SANA Common Stock Sale -$2.09K -333 -0.08% $6.28 429K Feb 18, 2022 Direct F3
holding SANA Common Stock 7.81K Feb 18, 2022 Held by The James J. MacDonald and Rena Chng Trust dtd 01/15/10
holding SANA Common Stock 125K Feb 18, 2022 Held by the KOM Trust
holding SANA Common Stock 125K Feb 18, 2022 Held by the NMM Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is voluntarily reporting the acquisition of shares of common stock of Sana Biotechnology, Inc. (the "Issuer") pursuant to the Sana Biotechnology, Inc. 2021 Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of February 3, 2021 through November 15, 2021. This transaction is exempt under Rule 16b-3(c).
F2 In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on November 15, 2021.
F3 The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 4, 2021.